Complement Therapeutics
Biotechnology company
Complement Therapeutics has raised €72M across 1 funding round from 7 investors, most recently a Series A round in Apr 2023. Based in Munich, Germany; active in Healthtech. Data as of 4 Nov 2026.
Munich, Germanycomplementtx.com ↗
Total raised
€72M
€72,000,000
Funding rounds
1
Investors
7
distinct backers
Active since
2023-04
latest 2023-04
Funding by year
EUR raised per yearComplement Therapeutics — funding by year — interactive chart.
Data table
| Complement Therapeutics — funding by year | |
|---|---|
| 2023 | €72M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-04-17 | Series A | €72M | BioGeneration Ventures,Cambridge Innovation Capital,Forbion,GIMV,Hadean Ventures,Panakès Partners+1 more | View deal → |
Investors
7Related news
- Complement Therapeutics Raises €72M in Series A Financingfinsmes.com · 2023-04
Similar companies
same sector, similar size- Medwing€72MGermany · Healthtech
- Resolve Biosciences€72MGermany · Healthtech
- Numares€62MGermany · Healthtech
- Infinite Roots (Mushlabs)€62MGermany · Healthtech
- Abalos Therapeutics€43MGermany · Healthtech
- Protembis€59MGermany · Healthtech
Global coverage: FundingData